Martinez-Fernandez A - Search Results

1

Stem cell platforms for regenerative medicine.

Nelson TJ, Behfar A, Yamada S, Martinez-Fernandez A, Terzic A. Nelson TJ, et al. Clin Transl Sci. 2009 Jun;2(3):222-7. doi: 10.1111/j.1752-8062.2009.00096.x. Clin Transl Sci. 2009. PMID: 19779576 Free PMC article.

2

KCNJ11 knockout morula re-engineered by stem cell diploid aggregation.

Nelson TJ, Martinez-Fernandez A, Terzic A. Nelson TJ, et al. Philos Trans R Soc Lond B Biol Sci. 2009 Jan 27;364(1514):269-76. doi: 10.1098/rstb.2008.0179. Philos Trans R Soc Lond B Biol Sci. 2009. PMID: 18977736 Free PMC article.

3

Repair of acute myocardial infarction by human stemness factors induced pluripotent stem cells.

Nelson TJ, Martinez-Fernandez A, Yamada S, Perez-Terzic C, Ikeda Y, Terzic A. Nelson TJ, et al. Circulation. 2009 Aug 4;120(5):408-16. doi: 10.1161/CIRCULATIONAHA.109.865154. Epub 2009 Jul 20. Circulation. 2009. PMID: 19620500 Free PMC article.

4

Induced pluripotent reprogramming from promiscuous human stemness related factors.

Nelson TJ, Martinez-Fernandez A, Yamada S, Mael AA, Terzic A, Ikeda Y. Nelson TJ, et al. Clin Transl Sci. 2009 Apr;2(2):118-26. doi: 10.1111/j.1752-8062.2009.00091.x. Clin Transl Sci. 2009. PMID: 20161095 Free PMC article.

5

c-MYC independent nuclear reprogramming favors cardiogenic potential of induced pluripotent stem cells.

Martinez-Fernandez A, Nelson TJ, Ikeda Y, Terzic A. Martinez-Fernandez A, et al. J Cardiovasc Transl Res. 2010 Feb;3(1):13-23. doi: 10.1007/s12265-009-9150-5. J Cardiovasc Transl Res. 2010. PMID: 20221419 Free PMC article.

6

Induced pluripotent stem cells: developmental biology to regenerative medicine.

Nelson TJ, Martinez-Fernandez A, Terzic A. Nelson TJ, et al. Nat Rev Cardiol. 2010 Dec;7(12):700-10. doi: 10.1038/nrcardio.2010.159. Epub 2010 Oct 19. Nat Rev Cardiol. 2010. PMID: 20956984 Review.

7

Nuclear reprogramming strategy modulates differentiation potential of induced pluripotent stem cells.

Martinez-Fernandez A, Nelson TJ, Terzic A. Martinez-Fernandez A, et al. J Cardiovasc Transl Res. 2011 Apr;4(2):131-7. doi: 10.1007/s12265-010-9250-2. Epub 2011 Jan 5. J Cardiovasc Transl Res. 2011. PMID: 21207217 Free PMC article. Review.

8

Nuclear reprogramming with c-Myc potentiates glycolytic capacity of derived induced pluripotent stem cells.

Folmes CD, Martinez-Fernandez A, Faustino RS, Yamada S, Perez-Terzic C, Nelson TJ, Terzic A. Folmes CD, et al. J Cardiovasc Transl Res. 2013 Feb;6(1):10-21. doi: 10.1007/s12265-012-9431-2. Epub 2012 Dec 18. J Cardiovasc Transl Res. 2013. PMID: 23247633 Free PMC article.

9

Inhibition of DNA topoisomerase II selectively reduces the threat of tumorigenicity following induced pluripotent stem cell-based myocardial therapy.

Wyles SP, Yamada S, Oommen S, Maleszewski JJ, Beraldi R, Martinez-Fernandez A, Terzic A, Nelson TJ. Wyles SP, et al. Stem Cells Dev. 2014 Oct 1;23(19):2274-82. doi: 10.1089/scd.2014.0259. Epub 2014 Aug 21. Stem Cells Dev. 2014. PMID: 25036735 Free PMC article.

10

iPS programmed without c-MYC yield proficient cardiogenesis for functional heart chimerism.

Martinez-Fernandez A, Nelson TJ, Yamada S, Reyes S, Alekseev AE, Perez-Terzic C, Ikeda Y, Terzic A. Martinez-Fernandez A, et al. Circ Res. 2009 Sep 25;105(7):648-56. doi: 10.1161/CIRCRESAHA.109.203109. Epub 2009 Aug 20. Circ Res. 2009. PMID: 19696409 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters